These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 26846697)
1. HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma. Liu X; Chen S; Tu J; Cai W; Xu Q Int J Mol Med; 2016 Mar; 37(3):825-35. PubMed ID: 26846697 [TBL] [Abstract][Full Text] [Related]
2. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509 [TBL] [Abstract][Full Text] [Related]
3. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861 [TBL] [Abstract][Full Text] [Related]
4. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation. Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013 [TBL] [Abstract][Full Text] [Related]
5. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways. Zhao ZX; Li S; Liu LX World J Gastroenterol; 2024 Jun; 30(21):2793-2816. PubMed ID: 38899332 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
7. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α. Chen P; Duan X; Li X; Li J; Ba Q; Wang H Oncogene; 2020 Apr; 39(14):2863-2876. PubMed ID: 32034309 [TBL] [Abstract][Full Text] [Related]
8. C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway. Kataria N; Martinez CA; Kerr B; Zaiter SS; Morgan M; McAlpine SR; Cook KM Cell Physiol Biochem; 2019; 53(3):480-495. PubMed ID: 31486323 [TBL] [Abstract][Full Text] [Related]
9. Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva. Pagoulatos D; Pharmakakis N; Lakoumentas J; Assimakopoulou M Mol Vis; 2014; 20():441-57. PubMed ID: 24715760 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
11. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced UBE2K promotes the malignant progression of HCC. Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132 [TBL] [Abstract][Full Text] [Related]
13. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo. Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447 [TBL] [Abstract][Full Text] [Related]
14. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma. Zhao F; Yu W; Hu J; Xia Y; Li Y; Liu S; Liu A; Wang C; Zhang H; Zhang L; Shi J Eur J Pharmacol; 2024 Jul; 974():176601. PubMed ID: 38677534 [TBL] [Abstract][Full Text] [Related]
16. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. Zhou J; Schmid T; Frank R; Brüne B J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529 [TBL] [Abstract][Full Text] [Related]
17. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114 [TBL] [Abstract][Full Text] [Related]
18. The epigallocatechin gallate derivative Y Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759 [TBL] [Abstract][Full Text] [Related]
19. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163 [TBL] [Abstract][Full Text] [Related]
20. Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression. Fang X; Zhang D; Zhao W; Gao L; Wang L Med Sci Monit; 2020 Aug; 26():e924670. PubMed ID: 32772041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]